Federated Hermes, Inc. Ultragenyx Pharmaceutical Inc. Transaction History

Federated Hermes, Inc.

  • $50.2 Billion
  • Q2 2025

A detailed history of Federated Hermes, Inc. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,049,501 shares of RARE stock, worth $63.2 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,049,501
Previous 2,055,200 0.28%
Holding current value
$63.2 Million
Previous $74.4 Million 0.14%
% of portfolio
0.15%
Previous 0.17%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$31.06 - $39.3 $177,010 - $223,970
-5,699 Reduced 0.28%
2,049,501 $74.5 Million
Q1 2025

May 08, 2025
BUY
$36.21 - $45.78 $195,534 - $247,212
5,400 Added 0.26%
2,055,200 $74.4 Million
Q4 2024

Feb 13, 2025
SELL
$42.07 - $57.72 $2.56 Million - $3.52 Million
-60,900 Reduced 2.89%
2,049,800 $86.2 Million
Q3 2024

Nov 13, 2024
BUY
$40.21 - $59.36 $147,771 - $218,148
3,675 Added 0.17%
2,110,700 $117 Million
Q2 2024

Aug 08, 2024
BUY
$37.42 - $51.61 $6.3 Million - $8.69 Million
168,345 Added 8.68%
2,107,025 $86.6 Million
Q1 2024

May 14, 2024
SELL
$43.02 - $53.69 $21.8 Million - $27.3 Million
-507,820 Reduced 20.76%
1,938,680 $90.5 Million
Q4 2023

Jan 31, 2024
BUY
$31.73 - $49.19 $7.93 Million - $12.3 Million
250,000 Added 11.38%
2,446,500 $117 Million
Q3 2023

Nov 13, 2023
BUY
$34.92 - $46.66 $14.7 Million - $19.6 Million
419,900 Added 23.64%
2,196,500 $78.3 Million
Q2 2023

Aug 14, 2023
SELL
$37.35 - $52.15 $28 Million - $39.1 Million
-749,000 Reduced 29.66%
1,776,600 $82 Million
Q1 2023

May 08, 2023
SELL
$36.99 - $48.71 $21 Million - $27.7 Million
-568,900 Reduced 18.38%
2,525,600 $101 Million
Q4 2022

Feb 13, 2023
SELL
$33.72 - $46.33 $24.3 Million - $33.4 Million
-721,897 Reduced 18.92%
3,094,500 $143 Million
Q3 2022

Nov 14, 2022
BUY
$39.96 - $66.14 $771,547 - $1.28 Million
19,308 Added 0.51%
3,816,397 $158 Million
Q2 2022

Aug 15, 2022
SELL
$45.8 - $85.4 $8.73 Million - $16.3 Million
-190,639 Reduced 4.78%
3,797,089 $227 Million
Q1 2022

May 13, 2022
BUY
$62.2 - $84.4 $53,367 - $72,415
858 Added 0.02%
3,987,728 $290 Million
Q4 2021

Feb 14, 2022
SELL
$73.71 - $87.86 $11,941 - $14,233
-162 Reduced -0.0%
3,986,870 $335 Million
Q3 2021

Nov 15, 2021
BUY
$77.92 - $102.4 $10.6 Million - $13.9 Million
135,722 Added 3.52%
3,987,032 $360 Million
Q2 2021

Aug 16, 2021
SELL
$92.19 - $115.71 $5.63 Million - $7.07 Million
-61,098 Reduced 1.56%
3,851,310 $367 Million
Q1 2021

May 13, 2021
SELL
$106.9 - $167.73 $39.4 Million - $61.7 Million
-368,120 Reduced 8.6%
3,912,408 $445 Million
Q4 2020

Feb 12, 2021
BUY
$84.4 - $177.39 $15.7 Million - $33 Million
186,213 Added 4.55%
4,280,528 $593 Million
Q3 2020

Nov 12, 2020
BUY
$72.98 - $90.0 $1.02 Million - $1.26 Million
13,956 Added 0.34%
4,094,315 $337 Million
Q2 2020

Aug 13, 2020
BUY
$46.91 - $78.22 $2.98 Million - $4.97 Million
63,599 Added 1.58%
4,080,359 $319 Million
Q1 2020

May 13, 2020
BUY
$33.8 - $62.9 $35.3 Million - $65.7 Million
1,044,752 Added 35.15%
4,016,760 $178 Million
Q4 2019

Feb 14, 2020
BUY
$36.08 - $45.83 $4.25 Million - $5.39 Million
117,698 Added 4.12%
2,972,008 $127 Million
Q3 2019

Nov 14, 2019
BUY
$42.5 - $63.11 $45.9 Million - $68.1 Million
1,079,658 Added 60.84%
2,854,310 $122 Million
Q2 2019

Aug 14, 2019
BUY
$54.93 - $74.36 $1.39 Million - $1.89 Million
25,378 Added 1.45%
1,774,652 $113 Million
Q1 2019

May 10, 2019
BUY
$39.87 - $69.36 $18.8 Million - $32.7 Million
471,955 Added 36.95%
1,749,274 $121 Million
Q4 2018

Feb 13, 2019
SELL
$38.89 - $77.3 $8.05 Million - $16 Million
-206,952 Reduced 13.94%
1,277,319 $55.5 Million
Q3 2018

Nov 13, 2018
BUY
$71.81 - $90.15 $4.79 Million - $6.01 Million
66,720 Added 4.71%
1,484,271 $113 Million
Q2 2018

Aug 10, 2018
BUY
$48.54 - $85.31 $10.6 Million - $18.6 Million
218,060 Added 18.18%
1,417,551 $109 Million
Q1 2018

May 09, 2018
BUY
$44.33 - $58.52 $4.37 Million - $5.78 Million
98,691 Added 8.97%
1,199,491 $61.2 Million
Q4 2017

Feb 14, 2018
BUY
$43.54 - $57.32 $30.9 Million - $40.7 Million
709,200 Added 181.1%
1,100,800 $0
Q3 2017

Nov 13, 2017
BUY
$49.79 - $66.32 $19.5 Million - $26 Million
391,600
391,600 $20.9 Million

Others Institutions Holding RARE

# of Institutions
365
Shares Held
88.1M
Call Options Held
3.64M
Put Options Held
2.24M
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $2.16B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email